KCP

gene
On this page

Also known as FLJ33365NET67

Summary

KCP (kielin cysteine rich BMP regulator, HGNC:17585) is a protein-coding gene on chromosome 7q32.1, encoding Kielin/chordin-like protein (Q6ZWJ8). Enhances bone morphogenetic protein (BMP) signaling in a paracrine manner.

Predicted to be involved in positive regulation of BMP signaling pathway. Predicted to act upstream of or within hematopoietic progenitor cell differentiation. Predicted to be located in extracellular space. Predicted to be active in extracellular region.

Source: NCBI Gene 375616 — RefSeq curated summary.

At a glance

  • GWAS associations: 1
  • Clinical variants (ClinVar): 290 total
  • MANE Select transcript: NM_001366122

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:17585
Approved symbolKCP
Namekielin cysteine rich BMP regulator
Location7q32.1
Locus typegene with protein product
StatusApproved
AliasesFLJ33365, NET67
Ensembl geneENSG00000135253
Ensembl biotypeprotein_coding
OMIM609344
Entrez375616

Gene structure

Transcript identifiers

Ensembl transcripts: 12 — 6 retained_intron, 2 protein_coding, 2 nonsense_mediated_decay, 2 protein_coding_CDS_not_defined

ENST00000460528, ENST00000492679, ENST00000610776, ENST00000611280, ENST00000612224, ENST00000613019, ENST00000616669, ENST00000676619, ENST00000676717, ENST00000678812, ENST00000678888, ENST00000679229

RefSeq mRNA: 2 — MANE Select: NM_001366122 NM_001366122, NM_199349

CCDS: CCDS94194

Canonical transcript exons

ENST00000610776 — 40 exons

ExonStartEnd
ENSE00003712612128878558128878722
ENSE00003712988128880997128881085
ENSE00003713238128876865128877311
ENSE00003714896128890905128891096
ENSE00003714978128910601128910709
ENSE00003715743128879522128879623
ENSE00003715852128903727128903820
ENSE00003717042128884781128884863
ENSE00003717642128884002128884122
ENSE00003717808128892688128892794
ENSE00003718192128880386128880528
ENSE00003718780128893976128894055
ENSE00003719614128891185128891278
ENSE00003721596128885097128885270
ENSE00003725090128886876128886966
ENSE00003726174128879913128880085
ENSE00003726417128886655128886737
ENSE00003727032128893806128893899
ENSE00003727782128888863128889039
ENSE00003729006128907101128907177
ENSE00003729303128892514128892607
ENSE00003730372128890343128890513
ENSE00003732925128881937128882016
ENSE00003734157128908426128908568
ENSE00003734462128879718128879829
ENSE00003736710128893391128893476
ENSE00003738134128877484128877790
ENSE00003738627128886464128886557
ENSE00003739918128891451128891533
ENSE00003743073128887215128887300
ENSE00003745323128893238128893319
ENSE00003745650128907264128907453
ENSE00003746903128891646128891819
ENSE00003748220128892869128893021
ENSE00003748576128902777128902859
ENSE00003748792128880619128880721
ENSE00003750305128894200128894293
ENSE00003751342128904056128904138
ENSE00003752275128881626128881725
ENSE00003752537128906279128906363

Expression profiles

Bgee: expression breadth ubiquitous, 165 present calls, max score 94.82.

FANTOM5 (CAGE): breadth broad, TPM avg 1.2377 / max 112.9415, expressed in 342 samples.

FANTOM5 promoters (6 alternative TSS)

Promoter IDTPM avgSamples expressed
860820.6635168
860830.4476167
860770.07815
860810.035011
860750.00994
860760.00363

Top tissues by expression

247 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
metanephros cortexUBERON:001053394.82gold quality
cerebellar hemisphereUBERON:000224592.93gold quality
right hemisphere of cerebellumUBERON:001489092.91gold quality
cerebellar cortexUBERON:000212992.81gold quality
cerebellumUBERON:000203790.39gold quality
hindlimb stylopod muscleUBERON:000425284.16gold quality
metanephrosUBERON:000008182.26gold quality
cortex of kidneyUBERON:000122581.98gold quality
adult mammalian kidneyUBERON:000008281.76gold quality
male germ line stem cell (sensu Vertebrata) in testisCL:0000089 ∩ UBERON:000047376.90gold quality
pancreatic ductal cellCL:000207976.52silver quality
kidneyUBERON:000211376.06gold quality
buccal mucosa cellCL:000233675.50silver quality
primordial germ cell in gonadCL:0000670 ∩ UBERON:000099175.30gold quality
gastrocnemiusUBERON:000138875.23gold quality
spermCL:000001975.20silver quality
small intestine Peyer’s patchUBERON:000345474.39gold quality
omental fat padUBERON:001041474.18gold quality
peritoneumUBERON:000235874.13gold quality
muscle of legUBERON:000138374.00gold quality
esophagus mucosaUBERON:000246973.99gold quality
prefrontal cortexUBERON:000045173.97gold quality
adipose tissue of abdominal regionUBERON:000780873.24gold quality
small intestineUBERON:000210872.66gold quality
stromal cell of endometriumCL:000225572.64gold quality
gall bladderUBERON:000211072.47gold quality
cortical plateUBERON:000534371.93gold quality
secondary oocyteCL:000065571.72silver quality
right frontal lobeUBERON:000281069.23gold quality
mucosa of stomachUBERON:000119968.59gold quality

Single-cell (SCXA)

Detected in 4 experiment(s), a significant marker in 3.

ExperimentMarker?Max mean expression
E-CURD-112yes14.89
E-MTAB-9543yes5.11
E-ANND-3yes4.34
E-MTAB-5061no3.51

Regulation

Is transcription factor: no

miRNA regulators (miRDB)

10 targeting KCP, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):

miRNAMax scoreAvg scoremiRNA target_count
HSA-MIR-6873-3P100.0071.422626
HSA-MIR-150-5P99.9966.691976
HSA-MIR-6778-3P99.9667.292693
HSA-MIR-6783-3P99.8967.922059
HSA-MIR-5010-3P99.8370.602357
HSA-MIR-6832-5P99.5864.821132
HSA-MIR-443799.5265.291266
HSA-MIR-504-3P99.3067.181745
HSA-MIR-939-3P98.9765.072347
HSA-MIR-122-5P97.2364.921024

Literature-anchored findings (GeneRIF, showing 2)

  • The KCP was closely associated with heart failure. The regulation of BMP2/7 and TGF-beta1 expression may be the possible mechanisms. (PMID:30144436)
  • Kielin/chordin-like protein enhances induction of osteoblast differentiation by Bone Morphogenetic Protein-2. (PMID:37226930)

Cross-species orthologs

3 orthologs

OrganismSymbolGene ID
danio_reriokcpENSDARG00000078508
mus_musculusKcpENSMUSG00000059022
rattus_norvegicusKcpENSRNOG00000021855

Paralogs (19): CHRDL2 (ENSG00000054938), CHRD (ENSG00000090539), CHRDL1 (ENSG00000101938), TECTA (ENSG00000109927), VWF (ENSG00000110799), MUC5B (ENSG00000117983), ZAN (ENSG00000146839), CRIM1 (ENSG00000150938), BMPER (ENSG00000164619), OTOGL (ENSG00000165899), VWCE (ENSG00000167992), VWC2L (ENSG00000174453), MUC6 (ENSG00000184956), OTOG (ENSG00000188162), VWC2 (ENSG00000188730), MUC2 (ENSG00000198788), MUC19 (ENSG00000205592), MUC5AC (ENSG00000215182), FCGBP (ENSG00000275395)

Protein

Protein identifiers

Kielin/chordin-like proteinQ6ZWJ8 (reviewed: Q6ZWJ8)

Alternative names: Cysteine-rich BMP regulator 2, Cysteine-rich motor neuron 2 protein, Kielin/chordin-like protein 1

All UniProt accessions (4): A0A087WVT8, A0A087WXB2, A0A7I2V446, Q6ZWJ8

UniProt curated annotations — full annotation on UniProt →

Function. Enhances bone morphogenetic protein (BMP) signaling in a paracrine manner. In contrast, it inhibits both the activin-A and TGFB1-mediated signaling pathways.

Subunit / interactions. Interacts with BMP7 and, by doing so, enhances binding to the type I receptors that contains cytoplasmic serine/threonine protein kinase domains. Also able to interact with activin-A and TGFB1.

Subcellular location. Secreted.

Miscellaneous. May be produced at very low levels due to a premature stop codon in the mRNA, leading to nonsense-mediated mRNA decay.

Isoforms (3)

UniProt IDNamesCanonical?
Q6ZWJ8-33yes
Q6ZWJ8-22
Q6ZWJ8-44

RefSeq proteins (1): NP_001353051* (*=MANE)

Domains & families (InterPro)

IDNameType
IPR001007VWF_domDomain
IPR001846VWF_type-DDomain
IPR014853VWF/SSPO/ZAN-like_Cys-rich_domDomain
IPR036084Ser_inhib-like_sfHomologous_superfamily
IPR052424Kielin_Chordin-BMP_RegFamily

Pfam: PF00093, PF00094, PF23334

UniProt features (39 total): domain 18, splice variant 6, sequence variant 4, glycosylation site 3, disulfide bond 2, signal peptide 1, chain 1, region of interest 1, coiled-coil region 1, compositionally biased region 1, sequence conflict 1

Structure

Experimental structures (PDB)

0 structures.

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-Q6ZWJ8-F172.350.06

Functional residue map

Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.

Disulfide bonds (2): 1215–1347, 1237–1388

Glycosylation sites (3): 340, 499, 1090

Function

Pathways and Gene Ontology

Reactome pathways

0 pathways

MSigDB gene sets: 61 (showing top): GOBP_REGULATION_OF_CELLULAR_RESPONSE_TO_GROWTH_FACTOR_STIMULUS, HNF1_Q6, LHX3_01, SREBP1_02, GOBP_POSITIVE_REGULATION_OF_BMP_SIGNALING_PATHWAY, NKX62_Q2, RGTTAMWNATT_HNF1_01, GOBP_REGULATION_OF_TRANSMEMBRANE_RECEPTOR_PROTEIN_SERINE_THREONINE_KINASE_SIGNALING_PATHWAY, GROSS_HYPOXIA_VIA_ELK3_ONLY_DN, chr7q32, GOBP_RESPONSE_TO_BMP, NKX25_01, GOBP_RESPONSE_TO_GROWTH_FACTOR, GOBP_REGULATION_OF_BMP_SIGNALING_PATHWAY, HNF1_01

GO Biological Process (2): positive regulation of BMP signaling pathway (GO:0030513), hematopoietic progenitor cell differentiation (GO:0002244)

GO Molecular Function (1): protein binding (GO:0005515)

GO Cellular Component (2): extracellular region (GO:0005576), obsolete extracellular space (GO:0005615)

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
BMP signaling pathway1
regulation of BMP signaling pathway1
positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway1
hemopoiesis1
cell differentiation1
binding1
cellular anatomical structure1

Protein interactions and networks

STRING

454 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
KCPBMP7P18075763
KCPLRRC8AQ8IWT6614
KCPTTYH2Q9BSA4564
KCPLRRC8EQ6NSJ5519
KCPLRRC8DQ7L1W4510
KCPLRRC8CQ8TDW0501
KCPTTYH3Q9C0H2472
KCPTTYH1Q9H313461
KCPCHRDQ9H2X0416
KCPTGFAP01135408
KCPLRRC8BQ6P9F7399
KCPCNNM1Q9NRU3380
KCPTMEM205Q6UW68356
KCPSTARD9Q9P2P6349
KCPMLANAQ16655349

IntAct

0 interactions, top by confidence:

ESM2 similar proteins: A2VEC9, O08644, O08852, O15197, O55225, O88839, O95428, O97507, P00748, P07204, P0C0K6, P0C0K7, P15306, P26010, P26011, P60882, P98140, P98167, Q00657, Q04912, Q04962, Q0V8J4, Q13444, Q2PC93, Q3U492, Q4G0T1, Q5IJ48, Q6GUQ1, Q6MG64, Q6MG84, Q6UVK1, Q6ZRI0, Q6ZWJ8, Q700K0, Q71U07, Q769J6, Q76LX8, Q7Z7M0, Q80YA8, Q8CG65

Diamond homologs: A2VEC9, A6QNY1, B3EWZ3, B3EWZ8, C0HL12, C5IAW9, D3YXG0, D3ZTD8, F1LW30, O08721, O08722, O08747, O14514, O15072, O55225, O60241, O60242, O75173, O88783, O95185, O95450, P04275, P07358, P07996, P27918, P35441, P35442, P35448, P55314, P57110, P58397, P58459, P59384, P79331, P80012, P97857, P98088, P98092, P98160, P98164

SIGNOR signaling

0 interactions.

Disease & clinical

Clinical variants and AI predictions

ClinVar

290 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic0
Likely pathogenic0
Uncertain significance251
Likely benign22
Benign0

Top pathogenic / likely-pathogenic (0)

SpliceAI

6705 predictions. Top by Δscore:

VariantEffectΔscore
7:128865372:CACA:Cacceptor_loss1.0000
7:128865374:CA:Cacceptor_loss1.0000
7:128865375:A:AGacceptor_gain1.0000
7:128865375:A:ATacceptor_loss1.0000
7:128865376:G:GGacceptor_gain1.0000
7:128865376:GGCA:Gacceptor_gain1.0000
7:128865376:GGCAA:Gacceptor_gain1.0000
7:128879518:GCA:Gdonor_loss1.0000
7:128879520:A:ATdonor_loss1.0000
7:128879712:GCTCA:Gdonor_loss1.0000
7:128879714:TCA:Tdonor_loss1.0000
7:128879715:CA:Cdonor_loss1.0000
7:128879716:A:ACdonor_gain1.0000
7:128879716:A:Cdonor_loss1.0000
7:128879717:C:CCdonor_gain1.0000
7:128879731:T:TAdonor_gain1.0000
7:128879825:GCACA:Gacceptor_gain1.0000
7:128879826:CACA:Cacceptor_gain1.0000
7:128879826:CACAC:Cacceptor_gain1.0000
7:128879827:ACA:Aacceptor_gain1.0000
7:128879828:CA:Cacceptor_gain1.0000
7:128879828:CAC:Cacceptor_gain1.0000
7:128879830:C:CCacceptor_gain1.0000
7:128880385:CGGGG:Cdonor_gain1.0000
7:128880995:A:ACdonor_gain1.0000
7:128880996:C:CCdonor_gain1.0000
7:128891735:T:Adonor_gain1.0000
7:128892510:ATAC:Adonor_loss1.0000
7:128892512:A:Cdonor_loss1.0000
7:128892513:CCT:Cdonor_loss1.0000

AlphaMissense

10573 scored. Top likely-pathogenic:

VariantProtein changeam_pathogenicity
7:128891491:A:CF617C0.996
7:128892978:C:AW441C0.996
7:128892978:C:GW441C0.996
7:128888997:A:CF797C0.995
7:128879967:A:CF1233C0.991
7:128892997:A:CF435C0.991
7:128878561:C:AW1376C0.990
7:128878561:C:GW1376C0.990
7:128885227:C:AW974C0.990
7:128885227:C:GW974C0.990
7:128877687:C:GC1412S0.988
7:128877688:A:TC1412S0.988
7:128879966:G:CF1233L0.987
7:128879966:G:TF1233L0.987
7:128879968:A:GF1233L0.987
7:128879967:A:GF1233S0.986
7:128892728:A:CF500C0.986
7:128884821:A:CF1032C0.985
7:128891490:G:CF617L0.985
7:128891490:G:TF617L0.985
7:128891491:A:GF617S0.985
7:128891492:A:GF617L0.985
7:128877503:C:AW1473C0.984
7:128877503:C:GW1473C0.984
7:128880473:C:AW1164C0.984
7:128880473:C:GW1164C0.984
7:128888996:G:CF797L0.984
7:128888996:G:TF797L0.984
7:128888998:A:GF797L0.984
7:128888997:A:GF797S0.981

dbSNP variants (sampled 300 via entrez): RS1000137428 (7:128909526 C>T), RS1000341189 (7:128903954 G>A), RS1000403868 (7:128890267 C>A,T), RS1000440640 (7:128897468 TTG>T), RS1000662463 (7:128901767 C>T), RS1000680947 (7:128878287 A>C,G,T), RS1000752859 (7:128878615 C>A,T), RS1000943480 (7:128900713 G>A,C), RS1001007548 (7:128893429 G>A,C), RS1001023687 (7:128879552 A>C,G,T), RS1001065636 (7:128887680 CACAT>C,CACATACAT), RS1001081908 (7:128884801 A>C,G), RS1001203153 (7:128910865 A>G), RS1001306233 (7:128910112 G>A,T), RS1001355323 (7:128893114 G>A,C)

Disease associations

OMIM: gene MIM:609344 | disease phenotypes:

GenCC curated gene-disease

Mondo (0):

Orphanet (0):

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

1 associations (top):

StudyTraitp-value
GCST009597_34Multiple sclerosis3.000000e-09

Drugs & pharmacology

Drug and pharmacology data

Is drug target: no

PharmGKB: 1 entry (VIP=true, CPIC=false)

CTD chemical–gene interactions

26 total (human), top 26 by PubMed support.

ChemicalActions (top 5)PubMed papers
Benzo(a)pyreneaffects methylation, increases expression, increases methylation3
sodium arsenitedecreases expression, increases expression2
Phenylmercuric Acetateaffects cotreatment, decreases expression2
Cadmium Chlorideincreases expression2
bisphenol Adecreases methylation1
arseniteincreases methylation1
4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamideaffects cotreatment, decreases expression1
nutlin 3affects cotreatment, increases expression1
abrineincreases expression1
dorsomorphinaffects cotreatment, decreases expression1
jinfukangaffects cotreatment, increases expression1
Resveratrolaffects cotreatment, decreases expression1
Acetaminophendecreases expression1
Glyphosateaffects methylation1
Air Pollutantsdecreases expression, increases abundance1
Cisplatinaffects cotreatment, increases expression1
Dactinomycinaffects cotreatment, increases expression1
Diethylhexyl Phthalatedecreases expression1
Epichlorohydrinaffects response to substance1
Formaldehydeincreases expression1
Plant Extractsaffects cotreatment, decreases expression1
Smokedecreases expression, increases abundance1
Tobacco Smoke Pollutiondecreases expression1
Valproic Acidincreases methylation1
Aflatoxin B1increases methylation1
Gold Compoundsincreases expression1

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.